Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  AJP - Renal Physiology

• Publication date

  2001-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPRENAL.2001.280.5.F823PMID 11292624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.

  2001cited by this paper
• Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome.

  1999cited by this paper
• New insights into lipid metabolism in the nephrotic syndrome.

  1999cited by this paper
• High Density Lipoproteins in Health and in Disease

  1999cited by this paper
• Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.

  1998cited by this paper
• Effect of long chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine on the interaction with recombinant high density lipoprotein apolipoprotein A-I.

  1998cited by this paper
• Down-regulation of hepatic lipase expression in experimental nephrotic syndrome.

  1997cited by this paper
• Gene expression of lipoprotein lipase in experimental nephrosis.

  1997cited by this paper
• Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction.

  1997cited by this paper
• The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes.

  1997cited by this paper
• Acquired VLDL receptor deficiency in experimental nephrosis.

  1997cited by this paper
• Cloning and in vitro expression of rat lecithin:cholesterol acyltransferase.

  1997cited by this paper
• Glycosylation structure and enzyme activity of lecithin:cholesterol acyltransferase from human plasma, HepG2 cells, and baculoviral and Chinese hamster ovary cell expression systems.

  1996cited by this paper
• Down-regulation of hepatic LDL receptor expression in experimental nephrosis.

  1996cited by this paper
• Gene expression of hepatic cholesterol 7 alpha-hydroxylase in the course of puromycin-induced nephrosis.

  1996cited by this paper
• Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis.

  1995cited by this paper
• Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.

  1994cited by this paper
• Response to HMG CoA reductase inhibitors in heterozygous familial hypercholesterolemia due to the 10-kb deletion ("French Canadian mutation") of the LDL receptor gene.

  1994cited by this paper
• Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome.

  1994cited by this paper
• Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats.

  1994cited by this paper
• Elevated Plasma Lipoprotein(a) in Patients with the Nephrotic Syndrome

  1993cited by this paper
• Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome

  1993cited by this paper
• Studies on abnormal lipid metabolism in experimental nephrotic syndrome.

  1993cited by this paper
• Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.

  1993cited by this paper
• Bile acid biosynthesis.

  1992cited by this paper
• Erythropoietin metabolism and pharmacokinetics in experimental nephrosis.

  1992cited by this paper
• The pituitary-gonadal axis in experimental nephrotic syndrome in male rats.

  1992cited by this paper
• Regulation of bile acid synthesis

  1991cited by this paper
• Factor XIII and its substrates, fibronectin, fibrinogen, and alpha 2-antiplasmin, in plasma and urine of patients with nephrosis.

  1991cited by this paper
• Structure-function relationships in human lecithin:cholesterol acyltransferase. Site-directed mutagenesis at serine residues 181 and 216.

  1991cited by this paper
• Vitamin D Absorption, Plasma Concentration and Urinary Excretion of 25-Hydroxyvitamin D in Nephrotic Syndrome

  1991cited by this paper
• Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin.

  1990cited by this paper
• Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.

  1990cited by this paper
• Lipopolysaccharide and tumor necrosis factor cause a fall in plasma concentration of lecithin: cholesterol acyltransferase in cynomolgus monkeys.

  1990cited by this paper
• Serum apolipoproteins A and B, lecithin: cholesterol acyl transferase activities and urinary cholesterol levels in nephrotic syndrome patients before and during steroid treatment.

  1990cited by this paper
• Plasma lipids and acyltransferase activities in experimental nephrotic syndrome.

  1989cited by this paper
• Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived choleste

  1989cited by this paper
• Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome.

  1984cited by this paper
• Urinary excretion and deficiency of prothrombin in nephrotic syndrome.

  1984cited by this paper
• Deficiency and urinary losses of factor XII in adult nephrotic syndrome.

  1982cited by this paper
• Thyroid function studies in the nephrotic syndrome.

  1979cited by this paper
• A role of ApoA-1 in LCAT reaction.

  1978cited by this paper
• Regulation of bile acid synthesis.

  1974cited by this paper
• A protein cofactor of lecithin:cholesterol acyltransferase.

  1972cited by this paper
• The plasma lecithins:cholesterol acyltransferase reaction.

  1968cited by this paper
• [The nephrotic syndrome].

  1965cited by this paper

• Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease.

  2026cites this paper
• Preliminary screening of urinary host protein biomarkers for Schistosomiasis haematobium: A proteome profiling study identifying candidate diagnostic targets in school-aged children

  2025cites this paper
• Membranous Nephropathy

  2025cites this paper
• Uncommon Factors Leading to Nephrotic Syndrome

  2025cites this paper
• Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews

  2024cites this paper
• LCAT- targeted therapies: Progress, failures and future.

  2022cites this paper
• Altered lipid metabolism and serum lipids in chronic kidney disease

  2022cites this paper
• Kidney and lipids: novel potential therapeutic targets for dyslipidemia in kidney disease?

  2022cites this paper
• HDL and Kidney Diseases.

  2022cites this paper
• Treatment With Lisinopril Prevents the Early Progression of Glomerular Injury in Obese Dahl Salt-Sensitive Rats Independent of Lowering Arterial Pressure

  2021cites this paper
• High-Density Lipoproteins and the Kidney

  2021cites this paper
• Assessment of Carotid Intima Media Thickness and Left Ventricular Mass Index in Children with Idiopathic Nephrotic Syndrome

  2021cites this paper
• Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases

  2021cites this paper
• Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease

  2020cites this paper
• Nephrotic Syndrome

  2020cites this paper
• Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome.

  2020cites this paper
• Endocrine Disorders in Kidney Disease

  2019cites this paper
• Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease Risk

  2019cites this paper
• Effect of Cholesterol and Niacin Supplementation on Serum Lipid Profile in Experimentally Induced Renal Dysfunction in Wistar Rats

  2019cites this paper
• Dyslipidemia and cardiovascular health in childhood nephrotic syndrome

  2019cites this paper
• University of Groningen Compositional Features of HDL Particles Interact with Albuminuria to Modulate Cardiovascular Disease

  2019cites this paper
• Lipid Disorders Associated with Chronic Kidney Disease and Nephrotic Syndrome

  2019cites this paper
• Lipoprotein Glomerulopathy, Non-AL Amyloidosis, LCAT, ING

  2019cites this paper
• Comparison of Cardiovascular Risk Between Diabetic & Non-Diabetic End Stage Renal Disease ( ESRD ) Patients Undergoing Haemodialysis

  2018influential citation
• Hyperlipidemia and associated risk factors: synthetic drugs or medicinal plants? An important question

  2017cites this paper
• Lipid profile abnormalities among nigerian male renal failure patients on dialysis

  2017cites this paper
• Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

  2016cites this paper
• Title Disorders of lipid metabolism in nephrotic syndrome : mechanisms and consequences

  2016cites this paper
• acyltransferase in chronic renal failure Downregulation of hepatic acyl-CoA:diglycerol

  2016cites this paper
• Pathophysiological mechanisms of dyslipidemia in patients with nephrotic syndrome: A fresh look

  2016cites this paper
• HDL abnormalities in nephrotic syndrome and chronic kidney disease

  2016cites this paper
• Advanced membranous nephropathy-like lesion in a Chinese patient with familial lecithin-cholesterol acyltransferase deficiency

  2016cites this paper
• Lipid profile and micro- and macrovascular complications in type 1 diabetes

  2015cites this paper
• HORMONAL AND LIPID PROFILE CHANGES IN MEN WITH CHRONIC RENAL FAILURE

  2015cites this paper
• Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome

  2015cites this paper
• In the Literature Dual Role of Circulating Angiopoietin-Like 4 ( ANGPTL 4 ) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome

  2014cites this paper
• Characteristic kidney pathology, gene abnormality and treatments in LCAT deficiency

  2014cites this paper
• Effects of lovastatin on hepatic expression of the low-density lipoprotein receptor in nephrotic rats.

  2014cites this paper
• Evaluation of drug interaction of glimepiride with phosphodiesterase inhibitors type V in diabetic nephropathy.

  2014cites this paper
• Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome.

  2014cites this paper
• 44. Nephrotic Syndrome

  2014cites this paper
• Natural antihyperlipidemic agents: Current status and future perspectives

  2013cites this paper
• Effects of combined prednisone + fluvastatin on cholesterol and bilirubin in pediatric patients with minimal change nephropathy.

  2013cites this paper
• Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome.

  2013cites this paper
• Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.

  2012cites this paper
• Management of dyslipidemia in CKD, dialysis and renal transplant recipient

  2012cites this paper
• Dyslipidemia acts as a close link between cardiovascular risk and renal progression in nephrotic children

  2012cites this paper
• Study of Alteration of Lipid Profile in Chronic KidneyDisease

  2012cites this paper
• Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins.

  2012cites this paper
• Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence: a case report and literature review.

  2011cites this paper
• Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor.

  2011cites this paper
• Mechanisms and Consequences of Proteinuria

  2011cites this paper
• Oxidized Low-Density Lipoprotein Is Negatively Correlated With Lecithin-Cholesterol Acyltransferase Activity in Type 2 Diabetes Mellitus

  2011cites this paper
• Role of free radicals and antioxidant status in childhood nephrotic syndrome

  2011cites this paper
• Role of reactive oxygen species in pathogenesis of nephrotic syndrome

  2010cites this paper
• Alterations of Lipid Metabolism in Chronic Nephropathies: Mechanisms, Diagnosis and Treatment

  2010cites this paper
• Hypertension and dyslipidemia in the pathophysiology of chronic kidney disease

  2009cites this paper
• Acquired severe hypercholesterolemia and hypoalphalipoproteinemia.

  2009cites this paper
• Analysis of Dyslipidemia in Nephrotic Syndrome by Capillary Isotachophoresis

  2009cites this paper
• Sterol Regulatory Element-Binding Proteins, Liver X Receptor, ABCA1 Transporter, CD36, Scavenger Receptors A1 and B1 in Nephrotic Kidney

  2009cites this paper
• Reverse Cholesterol Transport Pathway in Experimental Chronic Renal Failure

  2009cites this paper
• A study of omega-3 fatty acid therapy in patients with nephrotic syndrome

  2008cites this paper
• Oxidative Modification of Low-Density Lipoprotein in Relation to Dyslipidemia and Oxidant Status in Children With Steroid Sensitive Nephrotic Syndrome

  2008cites this paper
• Dyslipidemia in Chronic Kidney Disease: An Approach to Pathogenesis and Treatment

  2008cites this paper
• LECITHIN: CHOLESTEROL ACYLTRANSFERASE ACTIVITY IS DECREASED IN TYPE 2 DIABETES MELLITUS

  2007cites this paper
• Proteinuria increases oxylipid concentrations in VLDL and HDL but not LDL particles in the rat Published, JLR Papers in Press, May 11, 2007.

  2007cites this paper
• Lipids and renal disease.

  2006cites this paper
• The dyslipidemia of chronic renal disease: effects of statin therapy

  2006cites this paper
• Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

  2006cites this paper
• Dyslipidemia and nephrotic syndrome: recent advances.

  2005cites this paper
• Statins in nephrotic syndrome: A new weapon against tissue injury

  2005cites this paper
• Graded effects of proteinuria on HDL structure in nephrotic rats.

  2005cites this paper
• Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy.

  2005cites this paper
• Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.

  2004cites this paper
• Effects of HMG-CoA Reductase Inhibition on Hepatic Expression of Key Cholesterol-Regulatory Enzymes and Receptors in Nephrotic Syndrome

  2004cites this paper
• Upregulation of lipogenic enzymes genes expression in white adipose tissue of rats with chronic renal failure is associated with higher level of sterol regulatory element binding protein-1.

  2004cites this paper
• Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome

  2004cites this paper
• Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL.

  2004cites this paper
• AT-1 receptor blockade prevents proteinuria, renal failure, hyperlipidemia, and glomerulosclerosis in the Imai rat.

  2004cites this paper
• The Potential Role of HMG-CoA Reductase Inhibitors in Pediatric Nephrotic Syndrome

  2004cites this paper
• Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.

  2003cites this paper
• HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.

  2003cites this paper
• Dyslipidemia in pediatric nephrotic syndrome: causes revisited.

  2003cites this paper
• Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.

  2003cites this paper
• Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management

  2002cites this paper
• Hyperlipidemia in kidney disease: causes and consequences

  2002cites this paper
• Upregulation of acyl-CoA: cholesterol acyltransferase in chronic renal failure.

  2002cites this paper
• Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome.

  2002cites this paper
• Erythropoietin and transferrin metabolism in nephrotic syndrome.

  2001cites this paper